Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy.

Timothy E NewhookLaura R PrakashJose SolizShannon Hancher-HodgesB Bryce SpeerJonathan A WilksMorgan L BrunoWhitney L DewhurstElsa M ArvideJessica E MaxwellNaruhiko IkomaMichael P KimJeffrey E LeeMatthew H G KatzChing-Wei D Tzeng

Published in: Journal of surgical oncology (2021)

Transfusions given within 24 h are associated with dose-dependent decreases in survival after pancreatectomy for PDAC.

Keyphrases

end stage renal disease
prognostic factors
newly diagnosed
ejection fraction
lymph node
cardiac surgery
stem cells
mesenchymal stem cells
free survival
patient reported